Exhibit 99.1
| | |

| | 3560 Bassett Street, Santa Clara CA 95054 |
| | |
James Moniz | | Claire McAdams |
Chief Financial Officer | | Investor Relations |
(408) 986-9888 | | (530) 265-9899 |
INTEVAC ANNOUNCES THIRD QUARTER 2015 FINANCIAL RESULTS
Santa Clara, Calif.—November 2, 2015—Intevac, Inc. (Nasdaq: IVAC) today reported financial results for the quarter and nine months ended October 3, 2015.
“I’m pleased to report that in the third quarter we achieved the highest level of bookings in over two years, including over $19 million in Thin-film Equipment orders and over $8 million in Photonics orders,” commented Wendell Blonigan, Intevac’s president and chief executive officer. “Our Thin-film Equipment bookings in the third quarter demonstrated significant progress in our growth initiatives, winning Tier 1 customers for each of our new system orders: VERTEX PVD for protective coatings of display cover panels and MATRIX tools for solar metallization and implant.
“In our Photonics business, we were awarded a $25 million funding vehicle from the U.S. Army, as well as the initial grant of funding, for development of our next-generation night vision sensors. In 2015, we have seen our Photonics program engagements expand the total opportunity pipeline, which, combined with our recent successes establishing our Tier 1 foundation customers for our Thin-film Equipment growth initiatives, are key 2015 achievements that bode well for continued improvement in our financial performance in 2016 and beyond.”
| | | | | | | | | | | | | | | | |
($ Millions, except per share amounts) | | Q3 2015 | | | Q3 2014 | |
| | GAAP Results | | | Non-GAAP Results | | | GAAP Results | | | Non-GAAP Results | |
Net Revenues | | $ | 18.4 | | | $ | 18.4 | | | $ | 14.8 | | | $ | 14.8 | |
Operating Loss | | $ | (3.8 | ) | | $ | (3.9 | ) | | $ | (4.1 | ) | | $ | (4.2 | ) |
Net Loss | | $ | (3.8 | ) | | $ | (3.9 | ) | | $ | (3.6 | ) | | $ | (3.6 | ) |
Net Loss per Share | | $ | (0.17 | ) | | $ | (0.18 | ) | | $ | (0.15 | ) | | $ | (0.15 | ) |
| | |
| | Nine Months Ended October 3, 2015 | | | Nine Months Ended September 27, 2014 | |
| | GAAP Results | | | Non-GAAP Results | | | GAAP Results | | | Non-GAAP Results | |
Net Revenues | | $ | 58.8 | | | $ | 58.8 | | | $ | 46.5 | | | $ | 46.5 | |
Operating Loss | | $ | (6.4 | ) | | $ | (6.6 | ) | | $ | (14.1 | ) | | $ | (13.7 | ) |
Net Loss | | $ | (6.6 | ) | | $ | (6.8 | ) | | $ | (13.1 | ) | | $ | (12.8 | ) |
Net Loss per Share | | $ | (0.29 | ) | | $ | (0.30 | ) | | $ | (0.55 | ) | | $ | (0.54 | ) |
Intevac’s non-GAAP adjusted results exclude the impact of the following, where applicable: (1) changes in fair value of contingent consideration liabilities associated with business combinations; and (2) restructuring charges. A reconciliation of the GAAP and non-GAAP adjusted results is provided in the financial table included in this release. See also “Use of Non-GAAP Financial Measures” section.
Third Quarter 2015 Summary
The net loss for the quarter was $3.8 million, or $0.17 per share, compared to a net loss of $3.6 million, or $0.15 per share, in the third quarter of 2014. The non-GAAP net loss was $3.9 million or $0.18 per share. This compares to the third quarter 2014 non-GAAP net loss of $3.6 million or $0.15 per share.
Revenues were $18.4 million, including $9.2 million of Thin-film Equipment revenues and Photonics revenues of $9.2 million. Thin-film Equipment revenues included revenue recognition of the first MATRIX PVD system for solar panels, upgrades, spares and service. Photonics revenues included $2.1 million of research and development contracts. In the third quarter of 2014, revenues were $14.8 million, including $3.4 million of Thin-film Equipment revenues and Photonics revenues of $11.4 million, which included $2.5 million of research and development contracts.
Thin-film Equipment gross margin was 17.8% compared to (9.5)% in the third quarter of 2014 and 41.0% in the second quarter of 2015. The decline from the second quarter of 2015 reflected the lower margin on the first MATRIX PVD system for solar panels recognized for revenue. The improvement from the third quarter of 2014 reflected a higher level of revenue and improved factory absorption.
Photonics gross margin was 35.5% compared to 45.1% in the third quarter of 2014 and 34.5% in the second quarter of 2015. The decline from the third quarter of 2014 was due to lower contractual pricing on shipments of the Apache helicopter camera and higher factory overhead due to the modified cost structure implemented in the second quarter of 2015. Consolidated gross margin was 26.7%, compared to 32.6% in the third quarter of 2014 and 38.2% in the second quarter of 2015.
R&D and SG&A expenses were $8.8 million, compared to $9.0 million in the third quarter of 2014.
Order backlog totaled $52.8 million on October 3, 2015, compared to $43.5 million on July 4, 2015 and $43.9 million on September 27, 2014. Backlog at October 3, 2015 included three solar systems and one PVD display cover glass coating system. Backlog at July 4, 2015 included two solar systems. Backlog as of September 27, 2014 included one 200 Lean system, one solar system and one PVD display cover glass coating system.
The company ended the quarter with $56.1 million of total cash, restricted cash and investments and $82.0 million in tangible book value. The company repurchased 331 thousand shares of common stock for $1.7 million during the third quarter. As of October 3, 2015 the company has repurchased 3.3 million shares for $20.9 million out of the $30 million plan announced in November of 2013.
First Nine Months 2015 Summary
The net loss was $6.6 million, or $0.29 per share, compared to a net loss of $13.1 million, or $0.55 per share, for the first nine months of 2014. The non-GAAP net loss was $6.8 million or $0.30 per share. This compares to the first nine months of 2014 non-GAAP net loss of $12.8 million or $0.54 per share.
Revenues were $58.8 million, including $31.3 million of Thin-film Equipment revenues and Photonics revenues of $27.4 million, compared to revenues of $46.5 million, including $16.2 million of Thin-film Equipment revenues and Photonics revenues of $30.3 million, for the first nine months of 2014.
Thin-film Equipment gross margin was 30.0%, compared to 12.3% in the first nine months of 2014, the increase primarily due to higher mix of higher-margin upgrades, lower factory overhead
expenses and lower inventory charges. Photonics gross margin was 37.4% compared to 42.4% in the first nine months of 2014, reflecting lower contractual pricing on Apache camera shipments and higher factory overhead due to the modified cost structure implemented in the second quarter of 2015. Consolidated gross margin was 33.4%, compared to 31.9% in the first nine months of 2014.
R&D and SG&A expenses were $26.4 million and were down 8.5% from $28.9 million in the first nine months of 2014 primarily due to costs recovered under customer-funded NRE in Thin-film Equipment. Also 2014 operating expenses included costs associated with the proxy contest.
Use of Non-GAAP Financial Measures
Intevac’s non-GAAP results exclude the impact of the following, where applicable: (1) changes in fair value of contingent consideration liabilities associated with business combinations; and (2) restructuring charges. A reconciliation of the GAAP and non-GAAP results is provided in the financial tables included in this release.
Management uses non-GAAP results to evaluate the company’s operating and financial performance in light of business objectives and for planning purposes. These measures are not in accordance with GAAP and may differ from non-GAAP methods of accounting and reporting used by other companies. Intevac believes these measures enhance investors’ ability to review the company’s business from the same perspective as the company’s management and facilitate comparisons of this period’s results with prior periods. The presentation of this additional information should not be considered a substitute for results prepared in accordance with GAAP.
Conference Call Information
The company will discuss its financial results and outlook in a conference call today at 1:30 p.m. PST (4:30 p.m. EST). To participate in the teleconference, please call toll-free (877) 334-0811 prior to the start time. For international callers, the dial-in number is (408) 427-3734. You may also listen live via the Internet at the company’s website, www.intevac.com, under the Investors link, or at www.earnings.com. For those unable to attend, these web sites will host an archive of the call. Additionally, a telephone replay of the call will be available for 48 hours beginning today at 7:30 p.m. EST. You may access the replay by calling (855) 859-2056 or, for international callers, (404) 537-3406, and providing Replay Passcode 60960383.
About Intevac
Intevac was founded in 1991 and has two businesses: Thin-Film Equipment and Photonics.
In our Thin-Film Equipment business, we are a leader in the design and development of high-productivity, thin-film processing systems. Our production-proven platforms are designed for high-volume manufacturing of substrates with precise thin film properties.
Intevac is the market and technology leader in the hard drive industry, with our systems processing approximately 60% of all magnetic disk media produced worldwide. Our high-performance, high-throughput technology solutions continue to expand into additional markets – including solar and adjacent thin film deposition applications.
In our Photonics business, we are a recognized leading developer of advanced high-sensitivity digital sensors, cameras and systems that primarily serve the defense industry. We are the provider of integrated digital night vision imaging systems for the U.S. military.
For more information call 408-986-9888, or visit the company’s website atwww.intevac.com.
200 Lean® is a registered trademark and INTEVAC MATRIX™ and INTEVAC VERTEX™ are trademarks of Intevac, Inc.
Safe Harbor Statement
This press release includes statements that constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Intevac claims the protection of the safe-harbor for forward-looking statements contained in the Reform Act. These forward-looking statements are often characterized by the terms “may,” “believes,” “projects,” “expects,” or “anticipates,” and do not reflect historical facts. Specific forward-looking statements contained in this press release include, but are not limited to: the ability to leverage technology into new markets, customer penetration and adoption, and future revenue growth and profitability. The forward-looking statements contained herein involve risks and uncertainties that could cause actual results to differ materially from the company’s expectations. These risks include, but are not limited to: technology risk and challenges achieving customer adoption and commercial success in adjacent markets and delays in shipping deposition systems or Photonics cameras, each of which could have a material impact on our business, our financial results, and the company’s stock price. These risks and other factors are detailed in the company’s periodic filings with the U.S. Securities and Exchange Commission.
INTEVAC, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited, in thousands, except per share amounts)
| | | | | | | | | | | | | | | | |
| | Three months ended | | | Nine months ended | |
| | October 3, 2015 | | | September 27, 2014 | | | October 3, 2015 | | | September 27, 2014 | |
Net revenues | | | | | | | | | | | | | | | | |
Thin-film Equipment | | $ | 9,192 | | | $ | 3,375 | | | $ | 31,314 | | | $ | 16,184 | |
Photonics | | | 9,226 | | | | 11,382 | | | | 27,448 | | | | 30,304 | |
| | | | | | | | | | | | | | | | |
Total net revenues | | | 18,418 | | | | 14,757 | | | | 58,762 | | | | 46,488 | |
| | | | |
Gross profit | | | 4,912 | | | | 4,815 | | | | 19,640 | | | | 14,836 | |
Gross margin | | | | | | | | | | | | | | | | |
Thin-film Equipment | | | 17.8 | % | | | (9.5 | )% | | | 30.0 | % | | | 12.3 | % |
Photonics | | | 35.5 | % | | | 45.1 | % | | | 37.4 | % | | | 42.4 | % |
| | | | | | | | | | | | | | | | |
Consolidated | | | 26.7 | % | | | 32.6 | % | | | 33.4 | % | | | 31.9 | % |
| | | | |
Operating expenses | | | | | | | | | | | | | | | | |
Research and development | | | 3,956 | | | | 3,986 | | | | 11,511 | | | | 12,817 | |
Selling, general and administrative | | | 4,886 | | | | 4,991 | | | | 14,915 | | | | 16,055 | |
Acquisition-related1 | | | (150 | ) | | | (78 | ) | | | (350 | ) | | | 19 | |
| | | | | | | | | | | | | | | | |
Total operating expenses | | | 8,692 | | | | 8,899 | | | | 26,076 | | | | 28,891 | |
| | | | | | | | | | | | | | | | |
Total operating loss | | | (3,780 | ) | | | (4,084 | ) | | | (6,436 | ) | | | (14,055 | ) |
| | | | |
Operating income (loss) | | | | | | | | | | | | | | | | |
Thin-film Equipment | | | (3,935 | ) | | | (5,872 | ) | | | (7,226 | ) | | | (15,681 | ) |
Photonics | | | 1,308 | | | | 3,120 | | | | 4,060 | | | | 6,595 | |
Corporate | | | (1,153 | ) | | | (1,332 | ) | | | (3,270 | ) | | | (4,969 | ) |
| | | | | | | | | | | | | | | | |
Total operating income (loss) | | | (3,780 | ) | | | (4,084 | ) | | | (6,436 | ) | | | (14,055 | ) |
Interest income and other income (expense), net | | | 23 | | | | 113 | | | | 88 | | | | 306 | |
| | | | | | | | | | | | | | | | |
Loss before income taxes | | | (3,757 | ) | | | (3,971 | ) | | | (6,348 | ) | | | (13,749 | ) |
Provision for (benefit from) income taxes | | | 2 | | | | (412 | ) | | | 292 | | | | (662 | ) |
| | | | | | | | | | | | | | | | |
Net loss | | $ | (3,759 | ) | | $ | (3,559 | ) | | $ | (6,640 | ) | | $ | (13,087 | ) |
| | | | | | | | | | | | | | | | |
Net Loss per share | | | | | | | | | | | | | | | | |
Basic and Diluted | | $ | (0.17 | ) | | $ | (0.15 | ) | | $ | (0.29 | ) | | $ | (0.55 | ) |
Weighted average common shares outstanding | | | | | | | | | | | | | | | | |
Basic and Diluted | | | 22,004 | | | | 23,657 | | | | 22,621 | | | | 23,814 | |
1 | Results for all periods presented include changes in fair value of contingent consideration obligations associated with the Solar Implant Technology (SIT) acquisition in 2010. |
INTEVAC, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except par value)
| | | | | | | | |
| | October 3, 2015 | | | January 3, 2015 | |
| | (Unaudited) | | | (see Note) | |
ASSETS | | | | | | | | |
| | |
Current assets | | | | | | | | |
Cash, cash equivalents and short-term investments | | $ | 47,055 | | | $ | 51,080 | |
Accounts receivable, net | | | 13,558 | | | | 12,087 | |
Inventories | | | 15,659 | | | | 19,212 | |
Prepaid expenses and other current assets | | | 1,728 | | | | 1,727 | |
| | | | | | | | |
Total current assets | | | 78,000 | | | | 84,106 | |
Long-term investments | | | 7,303 | | | | 17,542 | |
Restricted cash | | | 1,780 | | | | 1,780 | |
Property, plant and equipment, net | | | 11,934 | | | | 12,826 | |
Intangible assets, net | | | 3,326 | | | | 3,966 | |
Other long-term assets | | | 1,540 | | | | 55 | |
| | | | | | | | |
Total assets | | $ | 103,883 | | | $ | 120,275 | |
| | | | | | | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | | | | |
| | |
Current liabilities | | | | | | | | |
Accounts payable | | $ | 4,233 | | | $ | 4,640 | |
Accrued payroll and related liabilities | | | 3,610 | | | | 3,977 | |
Other accrued liabilities | | | 3,806 | | | | 8,277 | |
Customer advances | | | 4,413 | | | | 2,551 | |
| | | | | | | | |
Total current liabilities | | | 16,062 | | | | 19,445 | |
| | |
Other long-term liabilities | | | 2,509 | | | | 2,200 | |
Stockholders’ equity | | | | | | | | |
Common stock ($0.001 par value) | | | 22 | | | | 23 | |
Additional paid-in capital | | | 165,668 | | | | 161,271 | |
Treasury stock, at cost | | | (20,937 | ) | | | (9,989 | ) |
Accumulated other comprehensive income | | | 493 | | | | 619 | |
Accumulated deficit | | | (59,934 | ) | | | (53,294 | ) |
| | | | | | | | |
Total stockholders’ equity | | | 85,312 | | | | 98,630 | |
| | | | | | | | |
Total liabilities and stockholders’ equity | | $ | 103,883 | | | $ | 120,275 | |
| | | | | | | | |
Note: Amounts as of January 3, 2015 are derived from the January 3, 2015 audited consolidated financial statements.
INTEVAC, INC.
RECONCILIATION OF GAAP TO NON-GAAP RESULTS
(Unaudited, in thousands, except per share amounts)
| | | | | | | | | | | | | | | | |
| | Three months ended | | | Nine months ended | |
| | October 3, 2015 | | | September 27, 2014 | | | October 3, 2015 | | | September 27, 2014 | |
Non-GAAP Loss from Operations | | | | | | | | | | | | | | | | |
Reported operating loss (GAAP basis) | | $ | (3,780 | ) | | $ | (4,084 | ) | | $ | (6,436 | ) | | $ | (14,055 | ) |
Change in fair value of contingent consideration obligations1 | | | (150 | ) | | | (78 | ) | | | (350 | ) | | | 19 | |
Restructuring charges2 | | | — | | | | — | | | | 148 | | | | 288 | |
| | | | | | | | | | | | | | | | |
Non-GAAP Operating Loss | | $ | (3,930 | ) | | $ | (4,162 | ) | | $ | (6,638 | ) | | $ | (13,748 | ) |
| | | | | | | | | | | | | | | | |
Non-GAAP Net Loss | | | | | | | | | | | | | | | | |
Reported net loss (GAAP basis) | | $ | (3,759 | ) | | $ | (3,559 | ) | | $ | (6,640 | ) | | $ | (13,087 | ) |
Change in fair value of contingent consideration obligations1 | | | (150 | ) | | | (78 | ) | | | (350 | ) | | | 19 | |
Restructuring charges2 | | | — | | | | — | | | | 148 | | | | 288 | |
| | | | | | | | | | | | | | | | |
Non-GAAP Net Loss | | $ | (3,909 | ) | | $ | (3,637 | ) | | $ | (6,842 | ) | | $ | (12,780 | ) |
| | | | | | | | | | | | | | | | |
Non-GAAP Net Loss Per Diluted Share | | | | | | | | | | | | | | | | |
Reported net loss per diluted share (GAAP basis) | | $ | (0.17 | ) | | $ | (0.15 | ) | | $ | (0.29 | ) | | $ | (0.55 | ) |
Change in fair value of contingent consideration obligations1 | | | (0.01 | ) | | | — | | | | (0.02 | ) | | | — | |
Restructuring charges2 | | | — | | | | — | | | | 0.01 | | | | 0.01 | |
| | | | | | | | | | | | | | | | |
Non-GAAP Net Loss Per Diluted Share | | $ | (0.18 | ) | | $ | (0.15 | ) | | $ | (0.30 | ) | | $ | (0.54 | ) |
| | | | | | | | | | | | | | | | |
Weighted average number of diluted shares | | | 22,004 | | | | 23,657 | | | | 22,621 | | | | 23,814 | |
1 | Results for all periods presented include changes in fair value of contingent consideration obligations associated with the Solar Implant Technology (SIT) acquisition in 2010. |
2 | Results for all periods presented include severance and other employee-related costs related to various restructuring programs. |